Portal de Periódicos da CAPES

Reproducibility of blood tests of liver fibrosis in clinical practice

2007; Elsevier BV; Volume: 41; Issue: 1-2 Linguagem: Inglês

10.1016/j.clinbiochem.2007.08.009

1873-2933

Paul Calès, Pascal Veillon, Anselme Konaté, E Mathieu, Catherine Ternisien, Alain Chevailler, Alban Godon, Yves Gallois, Françoise Joubaud, I. Hubert-Fouchard, Frédéric Oberti, Stéphane Reaud, Gilles Hunault, Françoise Mauriat, Françoise Lunel‐Fabiani,

Hepatitis C virus research

To evaluate the inter-laboratory reproducibility of blood test for liver fibrosis: FibroMeter, Fibrotest, APRI and their composites variables. Four studies, including 147 patients, were performed: study #1 included 2 metachronous blood samples and 2 laboratories; studies #2, #3 and #4 included synchronous samples with assays delayed at day 1 in 12 laboratories, at day 0 in 10 laboratories and at day 0 or 1 in 2 laboratories, respectively. Agreement was evaluated by the intraclass correlation coefficient (ric). In studies #1, #2 and #4, ric for FibroMeter was 0.893, 0.942 and 0.991, respectively. In study #3, the ric were: FibroMeter: 0.963, Fibrotest: 0.984, APRI: 0.949. Large simulated variations in composite variables had a weak impact on FibroMeter. When blood marker limits are controlled, inter-laboratory agreement of blood tests is excellent in clinical practice conditions. Blood tests are robust against the variability of composite blood variables.